Federated Hermes’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-398
Closed -$7.17K 2219
2025
Q1
$7.17K Sell
398
-2,002
-83% -$35.6K ﹤0.01% 1846
2024
Q4
$41.9K Sell
2,400
-442
-16% -$5.98K ﹤0.01% 1708
2024
Q3
$32.7K Sell
2,842
-763
-21% -$8.76K ﹤0.01% 1710
2024
Q2
$40.8K Buy
3,605
+1,474
+69% +$19.6K ﹤0.01% 1632
2024
Q1
$30.5K Sell
2,131
-1,345
-39% -$19.1K ﹤0.01% 1674
2023
Q4
$47.7K Buy
3,476
+1,818
+110% +$19.1K ﹤0.01% 1657
2023
Q3
$13.5K Buy
+1,658
New +$13.6K ﹤0.01% 1797
2021
Q3
Sell
-10,873
Closed -$164K 2333
2021
Q2
$164K Buy
10,873
+10,547
+3,235% +$158K ﹤0.01% 1711
2021
Q1
$4K Buy
+326
New +$5.06K ﹤0.01% 2084

Federated Hermes's PTVE Position: Q2 2025 in Review

Federated Hermes sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 398 shares — an estimated $7.17K sold.

Federated Hermes first reported a position in PTVE in Q1 2021 and held it in 9 quarters. The position peaked at $164K in Q2 2021. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Federated Hermes reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 398 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $7.17K.
  • Federated Hermes first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2021 and held it in 9 quarters.
  • Federated Hermes's Pactiv Evergreen Inc. Common stock position peaked at $164K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.